Immunic Inc. (IMUX) Misses Q2 EPS by 1c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Microsoft stock target cut at Wolfe on higher capex estimates
• Morgan Stanley turns cautious on freight stocks despite stronger cycle outlook